Cases Investigated

Beasley Allen is currently investigating the following cases involving unsafe medications. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

Beasley Allen representing Houston County against opioid companies

December 14, 2017 - In the second lawsuit filed in two days on behalf of a local government, Beasley Allen is representing Houston County against opioid manufacturers blamed for creating a public health crisis. Read More

Beasley Allen files lawsuit related to opioid epidemic for City of Greenville

December 13, 2017 - Lawyers from Beasley Allen are representing the City of Greenville against opioid manufacturers whose marketing efforts have contributed to the opioid epidemic and created a public health... Read More

More data links PPIs to kidney disease, failure

December 6, 2017 - Patients using proton pump inhibitors (PPIs) show a 33 percent increased risk of developing chronic kidney disease or kidney failure compared to non-PPI users. Read More

Number of Invokana MDL lawsuits grows

November 29, 2017 - In less than a year, the number of lawsuits consolidated under the Invokana Multidistrict Litigation (MDL) has grown from 55 to 865. Read More

Plaintiffs continue seeking justice over Xarelto adverse side effects

November 22, 2017 - Less than three years after Xarelto’s initial approval, the FDA issued black box warnings because of the Xarelto’s significant risk of severe, uncontrolled internal bleeding. Read More

Legal woes, health risks lead to shrinking testosterone therapy market

November 15, 2017 - The prescription-only drugs were first approved by the Food and Drug Administration (FDA) as treatment to increase testosterone levels in men with hypogonadism. Read More

New York man awarded $1M in Risperdal gynecomastia lawsuit

November 1, 2017 - Risperdal has been linked to a condition called gynecomastia, in which males grow female-like breasts. Some plaintiffs developed breasts as large as DD and the breasts may even lactate. Read More

Taxotere may add misery of permanent hair loss to breast cancer patients’ plight

October 25, 2017 - Some breast cancer survivors have also been left with an enduring, physical reminder of their battle – permanent alopecia – thanks to the cancer drug Taxotere. Read More

Litigation alleges GSK profits off billions in Zofran sales, subjects parents to unnecessary loss

October 11, 2017 - The underlying claim is that Zofran causes birth defects in babies born to women who used the drug while pregnant. Read More

Jury awards $140 million to Plaintiff in testosterone replacement therapy litigation

October 5, 2017 - A jury in Illinois federal court awarded Plaintiff Jeffrey Konrad $140 million in litigation involving testosterone replacement therapy (TRT). Read More

back to top